BioSphere Medical, Inc. (NASDAQ: BSMD) is focused on applying their proprietary microsphere technology to medical applications through the use of embolotherapy techniques. The company’s core technologies consist of patented bio-engineered polymers and manufacturing methods, which are used to produce miniature spherical beads with uniquely beneficial properties for a variety of medical applications. For further information, visit the Company’s web site at www.equityny.com.
- 17 years ago
QualityStocks
BioSphere Medical, Inc. (NASDAQ: BSMD)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – NextPlat Corp (NASDAQ: NXPL) Narrows Q2 Loss 66% as E-Commerce Growth Offsets Healthcare Headwinds
NextPlat (NASDAQ: NXPL, NXPLW), a global consumer products and services company in healthcare and technology,…
-
QualityStocksNewsBreaks – Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) Stands Distinct Against Walker Lane Backdrop
Lahontan Gold (TSX.V: LG) (OTCQB: LGCXF) is positioned as investors view the Walker Lane corridor in…
-
QualityStocksNewsBreaks – Solowin Holdings (NASDAQ: SWIN) Targets $1 Billion AUM for Tokenized USD Money Market Product by Year-End 2025
Solowin (NASDAQ: SWIN), a financial services firm bridging traditional and digital assets, announced an initiative…